Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO

Gareth P. Gregory, Jeremy S. Abramson, Huiqiang Huang, Qingyuan Zhang, Matthew Ku, Dok Hyun Yoon, Christopher P. Fox, Haifaa Abdulhaq, William Townsend, Joan Ashby, Alana Harris, Estefania Mulvihill, Martine Kallemeijn, Murali Kesavan, Richard Ta, Voleak Choeurng, Linda Lundberg, Huilai Zhang

Open source

DOI: 10.1016/j.clml.2026.10.007
Published: 2026-10
Container: Clinical Lymphoma Myeloma and Leukemia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2026.10.007,
  title = {Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO},
  author = {Gareth P. Gregory and Jeremy S. Abramson and Huiqiang Huang and Qingyuan Zhang and Matthew Ku and Dok Hyun Yoon and Christopher P. Fox and Haifaa Abdulhaq and William Townsend and Joan Ashby and Alana Harris and Estefania Mulvihill and Martine Kallemeijn and Murali Kesavan and Richard Ta and Voleak Choeurng and Linda Lundberg and Huilai Zhang},
  year = {2026},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  doi = {10.1016/j.clml.2026.10.007},
  url = {https://doi.org/10.1016/j.clml.2026.10.007}
}

RIS

TY  - JOUR
TI  - Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO
AU  - Gareth P. Gregory
AU  - Jeremy S. Abramson
AU  - Huiqiang Huang
AU  - Qingyuan Zhang
AU  - Matthew Ku
AU  - Dok Hyun Yoon
AU  - Christopher P. Fox
AU  - Haifaa Abdulhaq
AU  - William Townsend
AU  - Joan Ashby
AU  - Alana Harris
AU  - Estefania Mulvihill
AU  - Martine Kallemeijn
AU  - Murali Kesavan
AU  - Richard Ta
AU  - Voleak Choeurng
AU  - Linda Lundberg
AU  - Huilai Zhang
PY  - 2026
JO  - Clinical Lymphoma Myeloma and Leukemia
DO  - 10.1016/j.clml.2026.10.007
UR  - https://doi.org/10.1016/j.clml.2026.10.007
ER  -

APA

Gregory, G. P., Abramson, J. S., Huang, H., Zhang, Q., Ku, M., Yoon, D. H., Fox, C. P., Abdulhaq, H., Townsend, W., Ashby, J., Harris, A., Mulvihill, E., Kallemeijn, M., Kesavan, M., Ta, R., Choeurng, V., Lundberg, L., & Zhang, H. (2026). Patient-reported Outcomes in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Glofitamab Plus Gemcitabine and Oxaliplatin in STARGLO. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2026.10.007

Source records

crossref · retrieved 2026-11-09T07:25:08.602Z